• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用新一代装置经皮闭合房间隔缺损的早期至中期随访结果:单中心经验

Early to Mid-Term Follow-Up Outcomes of Percutaneous Closure of Atrial Septal Defects Using Recent Generation Devices: a Single-Center Experience.

作者信息

Kim Ah Young, Jung Se Yong, Chang Jenny Yeonsoo, Jung Jo Won, Choi Jae Young

机构信息

Division of Pediatric Cardiology, Center for Congenital Heart Disease, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Department of Biological Basis of Behavior, College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Korean Circ J. 2019 Apr;49(4):326-335. doi: 10.4070/kcj.2018.0278. Epub 2018 Dec 17.

DOI:10.4070/kcj.2018.0278
PMID:30808079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6428945/
Abstract

BACKGROUND AND OBJECTIVES

This study aimed to describe our early to mid-term experience with transcatheter atrial septal defect (ASD) closure using the Occlutech Figulla® Flex II device (FSO), Gore® Cardioform septal occluder (GSO), and Amplatzer® septal occluder (ASO) after they were first approved in Korea in 2014, and to compare the three aforementioned kinds of ASD closure devices.

METHODS

Between September 2014 and August 2016, 267 patients underwent transcatheter ASD closure in our institution. Baseline characteristics, hemodynamic features, comorbidities, and procedural success and complication rates were analyzed retrospectively. The unpaired Student t-test or variance analysis was used in the statistical analysis.

RESULTS

The FSO was most commonly used (n=152, 56.9%), followed by the ASO (n=98, 36.7%) and GSO (n=17, 6.4%). Baseline characteristics and hemodynamic features were similar between the devices, except that the defect size and pulmonary flow-to-systemic flow ratio were lower in the GSO group than in the other groups. Overall, the procedural success rate remained at 100%, and major complication rate was <1%. No late complication occurred during the follow-up.

CONCLUSIONS

The FSO and GSO are feasible, safe options for use in transcatheter ASD closure, and they are comparable to the ASO.

摘要

背景与目的

本研究旨在描述2014年经导管房间隔缺损(ASD)封堵术在韩国首次获批后,我们使用Occlutech Figulla® Flex II封堵器(FSO)、戈尔® Cardioform房间隔封堵器(GSO)和Amplatzer®房间隔封堵器(ASO)进行早期至中期治疗的经验,并比较上述三种ASD封堵装置。

方法

2014年9月至2016年8月期间,267例患者在本机构接受了经导管ASD封堵术。回顾性分析患者的基线特征、血流动力学特征、合并症以及手术成功率和并发症发生率。统计分析采用非配对t检验或方差分析。

结果

FSO使用最为频繁(n = 152,56.9%),其次是ASO(n = 98,36.7%)和GSO(n = 17,6.4%)。除GSO组的缺损大小和肺循环血流量与体循环血流量比值低于其他组外,各装置的基线特征和血流动力学特征相似。总体而言,手术成功率保持在100%,主要并发症发生率<1%。随访期间未发生晚期并发症。

结论

FSO和GSO是经导管ASD封堵术中可行、安全的选择,与ASO相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd3/6428945/d390ec4ce5ea/kcj-49-326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd3/6428945/d390ec4ce5ea/kcj-49-326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fd3/6428945/d390ec4ce5ea/kcj-49-326-g001.jpg

相似文献

1
Early to Mid-Term Follow-Up Outcomes of Percutaneous Closure of Atrial Septal Defects Using Recent Generation Devices: a Single-Center Experience.使用新一代装置经皮闭合房间隔缺损的早期至中期随访结果:单中心经验
Korean Circ J. 2019 Apr;49(4):326-335. doi: 10.4070/kcj.2018.0278. Epub 2018 Dec 17.
2
Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.使用菲古拉(Figulla®)房间隔缺损封堵器经导管封堵房间隔缺损:与安普利特泽(Amplatzer®)封堵器的对比研究。
Arch Cardiovasc Dis. 2015 Jan;108(1):57-63. doi: 10.1016/j.acvd.2014.09.005. Epub 2014 Nov 11.
3
Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.经导管封堵房间隔缺损:当前使用装置的综述
Cureus. 2023 Jun 8;15(6):e40132. doi: 10.7759/cureus.40132. eCollection 2023 Jun.
4
Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects.Figulla ASD 封堵器与 Amplatzer 房间隔封堵器:一种新型经皮房间隔缺损封堵装置的验证比较研究。
J Interv Cardiol. 2009 Dec;22(6):489-95. doi: 10.1111/j.1540-8183.2009.00497.x. Epub 2009 Sep 3.
5
UK multicenter experience using the Gore septal occluder (GSO(TM) ) for atrial septal defect closure in children and adults.英国使用戈尔间隔封堵器(GSO™)闭合儿童和成人房间隔缺损的多中心经验。
Catheter Cardiovasc Interv. 2014 Mar 1;83(4):581-6. doi: 10.1002/ccd.25216. Epub 2013 Nov 13.
6
Comparison of Figulla Flex® and Amplatzer™ devices for atrial septal defect closure: A meta-analysis.对比 Figulla Flex® 和 Amplatzer™ 封堵器在房间隔缺损封堵中的应用:一项荟萃分析。
Cardiol J. 2020;27(5):524-532. doi: 10.5603/CJ.a2020.0058. Epub 2020 Apr 24.
7
Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder.采用 Occlutech Figulla Flex II 与 Amplatzer Septal Occluder 封堵房间隔缺损的疗效和安全性比较。
Heart Vessels. 2021 May;36(5):704-709. doi: 10.1007/s00380-020-01739-1. Epub 2021 Jan 2.
8
Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.成人使用经皮经导管Cocoon房间隔封堵器闭合大型继发孔型房间隔缺损的临床结果
J Med Assoc Thai. 2013 Sep;96(9):1127-34.
9
A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects.一项比较 Occlutech Figulla Flex-II Occluder 与 Amplatzer Septal Occluder 经导管闭合继发孔型房间隔缺损的疗效和安全性的随机、对照、多中心临床试验。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):316-321. doi: 10.1002/ccd.27899. Epub 2018 Nov 4.
10
Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.儿童及青少年房间隔缺损的经导管封堵术:使用戈尔®房间隔封堵器的单中心经验
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):E51-7. doi: 10.1002/ccd.25494. Epub 2014 Aug 6.

引用本文的文献

1
Navigating the Uncertainties of Antithrombotic Therapy After Transcatheter Patent Foramen Ovale Closure: A Comprehensive Review.经导管卵圆孔未闭封堵术后抗栓治疗的不确定性探讨:一项综述
Catheter Cardiovasc Interv. 2025 Sep;106(3):2037-2047. doi: 10.1002/ccd.70049. Epub 2025 Jul 23.
2
Evaluation of short-term consequences of atrial septal defect closure in adults referred to Shahid Chamran heart center in Isfahan.对转诊至伊斯法罕沙希德·查姆兰心脏中心的成年人心房间隔缺损封堵术短期后果的评估。
ARYA Atheroscler. 2024;20(4):32-37. doi: 10.48305/arya.2024.31245.
3
Assessment of Device Neoendothelialization With Cardiac Computed Tomography Angiography After Transcatheter Closure of Atrial Septal Defect.

本文引用的文献

1
Transcatheter closure of atrial septal defect: principles and available devices.经导管房间隔缺损封堵术:原理与可用装置。
J Thorac Dis. 2018 Sep;10(Suppl 24):S2909-S2922. doi: 10.21037/jtd.2018.02.19.
2
Transcatheter closure of secundum atrial septal defects: has fear of device erosion altered outcomes?继发孔型房间隔缺损的经导管封堵术:对封堵器侵蚀的担忧是否改变了治疗结果?
Cardiol Young. 2017 Aug;27(6):1153-1161. doi: 10.1017/S1047951116002663. Epub 2017 Jan 12.
3
Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients.
经导管房间隔缺损封堵术后应用心脏计算机断层扫描血管造影评估装置的内皮化。
Circ Cardiovasc Imaging. 2022 Jul;15(7):e014138. doi: 10.1161/CIRCIMAGING.122.014138. Epub 2022 Jul 19.
4
Late Atrial Thrombus Formation After Percutaneous Patent Foramen Ovale Closure.经皮卵圆孔未闭封堵术后晚期心房血栓形成
JACC Case Rep. 2020 Apr 1;2(4):636-640. doi: 10.1016/j.jaccas.2020.01.010. eCollection 2020 Apr.
5
Percutaneous Atrial Septal Defect Closure Using the Occlutech Figulla Device in Adults: More than 800 Patient-Years of Follow-Up.经皮房间隔缺损封堵术使用 Occlutech Figulla 封堵器治疗成人:超过 800 患者-年的随访。
J Interv Cardiol. 2020 Feb 14;2020:7136802. doi: 10.1155/2020/7136802. eCollection 2020.
6
Closure of Atrial Septal Defects with the Recent Generation Devices.使用新一代装置闭合房间隔缺损
Korean Circ J. 2019 Apr;49(4):336-337. doi: 10.4070/kcj.2019.0077.
多中心使用戈尔房间隔封堵器治疗小儿房间隔缺损的中期随访结果。
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):E226-E232. doi: 10.1002/ccd.26881. Epub 2016 Nov 30.
4
The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry.主动脉后缘缺损对继发孔型房间隔缺损封堵术后技术成功率和早期不良事件的影响:IMPACT注册研究分析
Catheter Cardiovasc Interv. 2017 Jan;89(1):102-111. doi: 10.1002/ccd.26585. Epub 2016 May 18.
5
Historical developments of atrial septal defect closure devices: what we learn from the past.房间隔缺损封堵装置的历史发展:我们从过去中学到了什么。
Expert Rev Med Devices. 2016 Jun;13(6):555-68. doi: 10.1080/17434440.2016.1182860. Epub 2016 May 11.
6
Closure of Secundum Atrial Septal Defects by Using the Occlutech Occluder Devices in More Than 1300 Patients: The IRFACODE Project: A Retrospective Case Series.使用Occlutech封堵器装置闭合1300余例患者的继发孔型房间隔缺损:IRFACODE项目:一项回顾性病例系列研究
Catheter Cardiovasc Interv. 2016 Oct;88(4):571-581. doi: 10.1002/ccd.26497. Epub 2016 Mar 31.
7
Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.经导管封堵房间隔缺损后心脏侵蚀的相关危险因素:一项病例对照研究。
Circulation. 2016 May 3;133(18):1738-46. doi: 10.1161/CIRCULATIONAHA.115.019987. Epub 2016 Mar 21.
8
Comparison of the Occlutech ® Figulla ® septal occluder and Amplatzer ® septal occluder for atrial septal defect device closure.用于房间隔缺损封堵的Occlutech® Figulla® 房间隔封堵器与Amplatzer® 房间隔封堵器的比较。
Pediatr Cardiol. 2015 Jun;36(5):935-41. doi: 10.1007/s00246-015-1103-y. Epub 2015 Jan 30.
9
Optimal septum alignment of the Figulla Flex occluder to the atrial septum in patients with secundum atrial septal defects.继发孔型房间隔缺损患者中Figulla Flex封堵器与房间隔的最佳中隔对齐。
EuroIntervention. 2016 Feb;11(10):1153-60. doi: 10.4244/EIJY14M12_09.
10
Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.使用菲古拉(Figulla®)房间隔缺损封堵器经导管封堵房间隔缺损:与安普利特泽(Amplatzer®)封堵器的对比研究。
Arch Cardiovasc Dis. 2015 Jan;108(1):57-63. doi: 10.1016/j.acvd.2014.09.005. Epub 2014 Nov 11.